Chemokine α-5

Details Chemokine α-5 Chemokine α-5

2006-06-13

2006-06-13

Mertz, Prema (Department: 1646)

Drug, bio-affecting and body treating compositions

Lymphokine

C530S351000, C530S402000, C435S069500, C435S069700, C435S071100, C435S071200, C435S471000, C435S320100, C435S252300, C435S254110, C435S325000

Reexamination Certificate

active

07060261

ABSTRACT:
The present invention relates to a novel CKα-5 protein which is a member of the alpha chemokine family. In particular, isolated nucleic acid molecules are provided encoding the human CKα-5 protein. CKα-5 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of CKα-5 activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.

REFERENCES:
patent: 6319675 (2001-11-01), Briskin et al.
patent: WO-99/61471 (1999-12-01), None
patent: WO-01/37872 (2001-05-01), None
patent: WO-01/38874 (2001-05-01), None
Skolnick et al. Nature Biotechnology, vol. 18, (2000), pp. 283-287.
U.S. Appl. No. 09/912,293, Rosen et al.
Harlow et al. Antibodies A Laboratory Manual, Cold Spring Harbor Laboratory, Ch. 5, p. 76 (1988).
Mikayama et al., “Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor,” Proc. Natl. Acad. Sci. USA 90:10056-10060 (1993).
Voet et al. Biochemistry. John Wiley & Sons, Inc., pp. 126-128 and 228-234 (1990).
Rothenberg et al, “Murine eotaxin: An eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression,” Proc. Natl. Acad. Sci. USA 92:8960-8964 (1995).
Gonzalo et al, “Mouse EotaxinExpression Parallels Eosinophil Accumulation during Lung Allergic Inflammation but it is not restricted to a Th2-Type Response,” Immunity. 4:1-14 (1996).
Genbank Accession No. AA130776; Hillier et al, “Generation and analysis of 280,000 human expressed sequence tags,” Genome Res. 6(9):807-828 (1996).
Genbank Accession No. AA290712; Hillier et al, “Generation and analysis of 280,000 human expressed sequence tags,” Genome Res. 6(9):807-828 (1996).
Genbank Accession No. AA366329; Adams et al, “Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence,” Nature 377 (6547 Suppl):3-174 (1995).
Genbank Accession No. AA121716; Hillier, L. et al, “Generation and analysis of 280,000 human expressed sequence tags,” Genome Res. 6 (9): 807-828 (1996).
Genbank Accession No. AA146672; Hillier et al, “Generation and analysis of 280,000 human expressed sequence tags,” Genome Res. 6 (9): 807-828 (1996).
Genbank Accession No. AA149359; Hillier et al, “Generation and analysis of 280,000 human expressed sequence tags,” Genome Res. 6 (9): 807-828 (1996).
Genbank Accession No. AA147076; Hillier et al., “Generation and analysis of 280,000 human expressed sequence tags,” Genome Res. 6 (9): 807-828 (1996).
Genbank Accession No. AA577696; NCI-CGAP, National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index (1997).
Genbank Accession No. AA411655; Hillier et al., WashU-Merck EST Project (1997).
Genbank Accession No. AA121717; Hillier et al., Generation and analysis of 280,000 human expressed sequence tags, Genome Res. 6 (9): 807-828 (1996).
Genbank Accession No. AA151842; Hillier et al., “Generation and analysis of 280,000 human expressed sequence tags,” Genome Res. 6 (9): 807-828 (1996).
Genbank Accession No. AA416552; Hillier et al., WashU-Merck EST Project 1997.
Genbank Accession No. AA130627; Hillier et al., Generation and analysis of 280,000 human expressed sequence tags, Genome Res. 6 (9): 807-828 1996.
Genbank Accession No. AA411656; Hillier et al., WashU-Merck EST Project 1997.
Genbank Accession No. AA119688; Hillier et al., “Generation and analysis of 280,000 human expressed sequence tags,” Genome Res. 6 (9): 807-828 1996.
Genbank Accession No. AA235118; Hillier et al., Generation and analysis of 280,000 human expressed sequence tags, Genome Res. 6 (9): 807-828 1996.
Genbank Accession No. AA625220; Hillier et al., WashU-NCI human EST Project 1997.
Genbank Accession No. AI061333; Hillier et al., WashU-NCI human EST Project 1997.
Genbank Accession No. AI358175; NCI-CGAP, National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index (1997).
Genbank Accession No. AI624569; NCI-CGAP, National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index (1997).
Genbank Accession No. AA857255;NCI-CGAP, National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index (1997).
Genbank Accession No. AI344574; NCI-CGAP, National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index (1997).
Genbank Accession No. AI264137; NCI-CGAP, National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index (1997).
Genbank Accession No. AI828235; NCI-CGAP, National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index (1997).
Genbank Accession No. N22788; Hillier, L. et al., Generation and analysis of 280,000 human expressed sequence tags, Genome Res. 6 (9):807-828 (1996).
Claverie, J.M. and Makalowski, W. “Alu Alert,” Nature 371 (6500), 752 (1994).
Claverie, J.M., “Identifying coding exons by similarity search alu-derived and other potentially misleading protein sequences,” Genomics 12 (4), 838-841 (1992).
Quentin, Y., “The Alu family developed through successive waves of fixation closely connected with primate lineage history,” J. Mol. Evol. 27 (3), 194-202 (1998).
Jurka, J. and Milosavljevic, A, “Reconstruction and analysis of human Alu genes,” J. Mol. Evol. 32 (2), 105-121 (1991).
Fukumoto et al., “Critical roles of CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in the pathogenesis of both acute and adoptive transfer experimental autoimmune encephalomyelitis,” J. Immunol. 173:1620-27 (2004).
Shimaoka et al., “Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain,” J Immunol. 171(4):1647-51 (2003).
Shimaoka et al., “Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages,” J Biol Chem. 275(52):40663-6 (2000).
Wilbanks et al., “Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines,” J Immunol. 166(8):5145-54 (2001)###.
Chandrasekar et al., “CXCL 16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation,” J Biol Chem. 279(5):3188-96 (2004).
Wuttge et al., “CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions,” Arterioscler Thromb Vasc Biol. 24(4):750-5 (2004).
Yamauchi et al., “Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease,” Arterioscler Thromb Vasc Biol. 24(2):282-7 (2004).

Affiliated with

Also associated with

Rating

Chemokine α-5 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemokine α-5, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemokine α-5 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3651561